Chemical Structure : BMS-191011
CAS No.: 202821-81-6
Catalog No.: PC-38451Not For Human Use, Lab Use Only.
BMS-191011 (BMS-A) is a small molecule activator of large-conductance calcium-activated potassium (KCa1.1/BK) channels, increases current to 126% over control at 1 uM.
Packing | Price | Stock | Quantity |
---|---|---|---|
10 mg | $88 | In stock | |
25 mg | $148 | In stock | |
50 mg | $258 | In stock | |
100 mg | $428 | In stock | |
250 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
BMS-191011 (BMS-A) is a small molecule activator of large-conductance calcium-activated potassium (KCa1.1/BK) channels, increases current to 126% over control at 1 uM.
BMS-191011 (10-100 ug/kg, i.v.) increased the diameter of retinal arterioles without altering systemic blood pressure and heart rate significantly.
BMS-191011 could completely abolished iberiotoxin-induced vasodilator effects of acetylcholine on retinal arterioles in non-diabetic rats.
M.Wt | 370.7 | |
Formula | C16H10ClF3N2O3 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
3-[(5-chloro-2-hydroxyphenyl)methyl]-5-[4-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2(3H)-one |
1. Mori A, et al. Biol Pharm Bull. 2011;34(1):150-2.
2. Romine JL, et al. J Med Chem. 2007 Feb 8;50(3):528-42.
3. Hewawasam P, et al. Bioorg Med Chem Lett. 2003 May 19;13(10):1695-8.
4. Mori A, et al. Eur J Pharmacol. 2011 Nov 1;669(1-3):94-9.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright